1. Home
  2. GHRS vs XPOF Comparison

GHRS vs XPOF Comparison

Compare GHRS & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GHRS
  • XPOF
  • Stock Information
  • Founded
  • GHRS 2018
  • XPOF 2017
  • Country
  • GHRS Ireland
  • XPOF United States
  • Employees
  • GHRS 49
  • XPOF N/A
  • Industry
  • GHRS Biotechnology: Pharmaceutical Preparations
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • GHRS Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • GHRS Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • GHRS 356.4M
  • XPOF 388.8M
  • IPO Year
  • GHRS 2021
  • XPOF 2021
  • Fundamental
  • Price
  • GHRS $6.85
  • XPOF $13.85
  • Analyst Decision
  • GHRS Strong Buy
  • XPOF Buy
  • Analyst Count
  • GHRS 3
  • XPOF 10
  • Target Price
  • GHRS $35.67
  • XPOF $16.75
  • AVG Volume (30 Days)
  • GHRS 58.0K
  • XPOF 448.5K
  • Earning Date
  • GHRS 11-14-2024
  • XPOF 11-07-2024
  • Dividend Yield
  • GHRS N/A
  • XPOF N/A
  • EPS Growth
  • GHRS N/A
  • XPOF N/A
  • EPS
  • GHRS N/A
  • XPOF N/A
  • Revenue
  • GHRS N/A
  • XPOF $326,724,000.00
  • Revenue This Year
  • GHRS N/A
  • XPOF $1.79
  • Revenue Next Year
  • GHRS N/A
  • XPOF $7.50
  • P/E Ratio
  • GHRS N/A
  • XPOF N/A
  • Revenue Growth
  • GHRS N/A
  • XPOF 9.00
  • 52 Week Low
  • GHRS $5.08
  • XPOF $7.40
  • 52 Week High
  • GHRS $14.99
  • XPOF $18.95
  • Technical
  • Relative Strength Index (RSI)
  • GHRS 35.35
  • XPOF 43.01
  • Support Level
  • GHRS $7.20
  • XPOF $13.58
  • Resistance Level
  • GHRS $8.91
  • XPOF $16.00
  • Average True Range (ATR)
  • GHRS 0.86
  • XPOF 0.84
  • MACD
  • GHRS -0.18
  • XPOF -0.22
  • Stochastic Oscillator
  • GHRS 3.96
  • XPOF 11.48

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. The company is focused on developing novel and proprietary Mebufotenin 5-Methoxy-N, N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: